← Eichor
Study identifier: NCT07290153 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC

Condition: Breast Cancer Female NOS · General Anxiety Disorder · Depressive Disorder  ·  Sponsor: Fudan University

PhaseN/A
Planned participants120
Who can joinFemale, 18 Years to 70 Years
Healthy volunteersNo

About this study

This study aims to evaluate whether psychological status affects the response to neoadjuvant immunotherapy in triple-negative breast cancer (TNBC) and how it relates to immune changes during treatment. Participants will receive standard therapy, undergo psychological assessments, and provide blood and saliva samples for biomarker testing. By linking psychological status with immune profiles and treatment outcomes, the study seeks to clarify how mental state may influence immunotherapy effectiveness.

This description comes directly from the study's public registry record.

Talk to the study team

Zhi-Ming Shao  ·  +86-021-64175590  ·  zhimin_shao@yeah.net

Always discuss trial participation with your own doctor first.

Locations (1)

Fudan University Shangahi Cancer CenterShanghai, Please Select, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07290153